New insider activity at Becton Dickinson ( (BDX) ) has taken place on August 11, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Director Gregory Hayes has made a significant investment in Becton Dickinson by purchasing 5,250 shares of the company’s stock. This transaction is valued at an impressive $1,005,742, highlighting a strong vote of confidence in the company’s future prospects.
Recent Updates on BDX stock
Becton, Dickinson and Co (BDX) recently announced the completion of a clinical study evaluating the PureWick™ System, a non-invasive urine management device, against an established comparator. This study, significant for its potential to improve quality of life for individuals with nighttime urinary incontinence, could positively impact BDX’s stock performance by boosting investor confidence in the product’s market viability. As the healthcare sector continues to prioritize non-invasive solutions, this development may enhance BDX’s competitive positioning.
Spark’s Take on BDX Stock
According to Spark, TipRanks’ AI Analyst, BDX is a Outperform.
Becton Dickinson’s overall stock score reflects its strong financial performance, strategic initiatives, and positive earnings outlook. The company’s robust revenue growth, improved margins, and strategic transactions position it well for future growth. However, valuation concerns and market challenges in China present potential risks. The technical indicators suggest short-term positive momentum, supporting the overall positive outlook.
To see Spark’s full report on BDX stock, click here.
More about Becton Dickinson
YTD Price Performance: -13.80%
Average Trading Volume: 2,962,243
Technical Sentiment Signal: Sell
Current Market Cap: $55.46B